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In this report, we establish that Drosophila ADAR
(adenosine deaminase acting on RNA) forms a dimer
on double-stranded (ds) RNA, a process essential for
editing activity. The minimum region required for
dimerization is the N-terminus and dsRNA-binding
domain 1 (dsRBD1). Single point mutations within
dsRBD1 abolish RNA-binding activity and dimer
formation. These mutations and glycerol gradient
analysis indicate that binding to dsRNA is important
for dimerization. However, dimerization can be
uncoupled from dsRNA-binding activity, as a deletion
of the N-terminus (amino acids 1±46) yields a mono-
meric ADAR that retains the ability to bind dsRNA
but is inactive in an editing assay, demonstrating that
ADAR is only active as a dimer. Different isoforms of
ADAR with different editing activities can form
heterodimers and this can have a signi®cant effect on
editing in vitro as well as in vivo. We propose a model
for ADAR dimerization whereby ADAR monomers
®rst contact dsRNA; however, it is only when the





With the completion of genome sequences, interest has
focused on the diversity in gene products arising from
alternative splicing and RNA editing (Caceres and
Kornblihtt, 2002; Schaub and Keller, 2002). The most
common type of RNA editing found in vertebrates and
invertebrates is the conversion of speci®c adenosines to
inosine by the ADAR (adenosine deaminase acting on
RNA) family of enzymes (Keegan et al., 2001). ADARs
bind to an imperfect double-stranded (ds) RNA duplex
within the target transcript, formed between the target
exon and sequences in a ¯anking intron, and deaminate
speci®c adenosines usually with <100% ef®ciency.
Inosine is read as if it were guanosine by the translation
machinery, so a consequence of editing is that codons can
be changed. Most of the transcripts that are edited encode
receptors of the central nervous system (CNS), and
aberrant editing occurs in various disorders ranging from
epilepsy to malignant brain gliomas (Higuchi et al., 2000;
Maas et al., 2001; Sodhi et al., 2001). In addition, ADAR
knockouts in mice and ¯ies have unambiguously demon-
strated that RNA editing is required to create a full
repertoire of receptors in the CNS (Seeburg et al., 1998,
2001; Higuchi et al., 2000; Palladino et al., 2000a).
ADARs also deaminate long perfect duplex RNA, which
potentially opposes the RNA interference process, and
ADAR mutations in Caenorhabditis elegans increase
transgene-induced gene silencing (Knight and Bass, 2002).
RNA editing can profoundly alter ion selectivity and
gating properties of ion channels (Sommer et al., 1991;
Higuchi et al., 2000) as well as subunit maturation and
transport from the endoplasmic reticulum to the cell
membrane (Greger et al., 2002). For example, the calcium
permeability of the a-amino-3-hydroxy-5-methyl-4-iso-
xazolepropionic acid (AMPA) class of glutamate receptor
is reduced by editing of the glutamate-gated receptor
subunit B (GluR-B) transcript at the Q/R site (Sommer
et al., 1991). Inclusion of arginine-containing GluR-B
subunits within the heterotetrameric AMPA receptor both
reduces calcium permeability and also restricts the ¯ow of
receptors to synapses. Editing of transcripts encoding the
serotonin 5-HT2C receptor occurs at ®ve positions that can
produce at least 12 different protein isoforms in humans
(Niswender et al., 1999), with some isoforms displaying
reduced coupling of the receptor to G protein (Burns et al.,
1997). The edited and unedited isoforms of 5-HT2C
receptor display differences in sensitivity to lysergic acid
diethylamide (LSD) and antipsychotic drugs, implying an
effect of editing on responses to drugs that are often used
in psychiatric disorders (Berg et al., 2001; Sodhi et al.,
2001).
Transcripts that are edited in Drosophila also encode
ion channel subunits, but the number of sites per transcript
is more than is found in vertebrates. The cacophony (cac)
transcript encoding the pore-forming a1 subunit of a
voltage-gated calcium channel is edited at 12 sites
(Kawasaki et al., 2002). Transcripts encoding the a1
subunit of a voltage-gated sodium channel are also highly
edited (Hanrahan et al., 2000), whereas the glutamate-
gated chloride channel (GluCla) transcript is edited at ®ve
sites in ¯ies (Semenov and Pak, 1999).
All ADAR proteins share a similar domain structure;
they contain either two or three dsRNA-binding domains
(dsRBDs) and a catalytic deaminase domain in the
C-terminus. ADARs are considered members of the
cytidine deaminase (CDA) family due to the conservation
of key residues believed to chelate zinc within their
catalytic domains (Gerber and Keller, 1999). The amino
acids important for catalysis in CDA enzymes are
conserved in the ADATs (adenosine deaminases acting
on tRNA), APOBEC-1 (apoB RNA-editing CDA
subunit 1) and ADAR gene families. Indeed, mutagenesis
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experiments in which the putative catalytic residues in
ADARs were targeted demonstrated the similarity be-
tween ADARs and CDA gene families (Lai et al., 1995).
Many enzymes in the CDA family, including Escherichia
coli CDA, T4 bacteriophage CDA, APOBEC-1 and
particularly the adenosine deaminases Tad2/Tad3 and
TadA, function as homodimers or heterodimers (Betts
et al., 1994; Lau et al., 1994; Navaratnam et al., 1998;
Gerber and Keller, 1999; Wolf et al., 2002). Puri®ed
ADARs are monomers, and the predicted dsRNA struc-
tures at speci®c editing sites do not show any obvious
symmetrical structure that would suggest ADAR dimer
formation.
The dsRBDs of ADARs are highly homologous to those
found in other dsRNA-binding proteins such as PKR
(dsRNA-dependent protein kinase), Staufen and RNase
III. These proteins also form dimers and do so via their
dsRBDs (Cosentino et al., 1995; Wu and Kaufman, 1997;
Patel and Sen, 1998; Romano et al., 1998; Lamontagne
et al., 2000).
Due to the homology between Drosophila ADAR and
other proteins that form dimers, we wondered whether
ADARs also function as dimers. In this study, we show
that the dADAR protein does dimerize; however, unlike
CDA and Tad2/Tad3 proteins, the deaminase domain is
not required. Rather, the dimerization of ADAR resembles
that of PKR, as the minimum domain required for
dimerization is the N-terminus and ®rst dsRBD. Binding
to dsRNA is important to form a stable dimer, but these
two properties of binding and dimerization can be
dissociated. We demonstrate that a member of the
ADAR family is active only as a dimer. Flies containing
both the endogenous wild-type protein and an inactive
isoform expressed from a transgene show less than wild-
type levels of editing at speci®c sites. Different naturally
occurring isoforms of ADAR that display different RNA
binding as well as editing activities can form heterodimers
with important consequences for the ®nal editing activity
in vitro. These ®ndings suggest that ADAR isoforms with
slightly different editing activities can combine to increase
the repertoire of editing events that occur at a speci®c time
or in a speci®c cell type.
Results
Dimerization of dADAR
The ADAR 3a isoform (Figure 1A) was used in all
experiments in this study unless otherwise indicated. To
determine whether ADAR monomers interact, a yeast two-
hybrid assay was used. The yeast strain L40 was
cotransformed with plasmids encoding the full-length
Adar 3a isoform (Figure 1A) fused to either the LexA
DNA-binding domain or to the transcription activation
domain (AD) of GAL4. The cotransformed yeast L40 cells
were plated on selective media with increasing concen-
trations of 3-aminotriazole (3-AT) to reduce the non-
speci®c background. Positive protein±protein interactions
were detected as colonies that turned blue within 20 min in
a b-galactoside ®lter lift assay. Full-length ADAR was
found to dimerize in the two-hybrid assay (Figure 2A).
This interaction was still observed when the concentration
of 3-AT was increased to 5 mM, indicating a strong ADAR
dimerization. Only 1.5 mM 3-AT was required to elim-
inate non-speci®c background. As controls, each fusion
construct was independently tested with the plasmid
expressing either the LexA DNA-binding domain or the
activation domain of GAL4 alone (Figure 2A).
ADAR dimerization was con®rmed by in vitro co-
immunoprecipitation of in vitro-translated proteins.
Plasmid constructs bearing a T7 promoter sequence
upstream of full-length Adar 3a sequence fused to either
a c-Myc or an HA epitope tag were separately transcribed
and translated in vitro with a coupled rabbit reticulocyte
system. Equal amounts of the recombinant c-Myc and HA
epitope-tagged ADARs were mixed and immunoprecipi-
tated with polyclonal anti-c-Myc antibody coupled to
protein G±agarose beads. The immunoprecipitated pro-
teins were detected by western blot analysis with an anti-
HA antibody (Figure 2B). To con®rm this result, the
reciprocal experiment was also performed in which ADAR
was immunoprecipitated with the anti-HA antibody and
detected by western blot analysis with an anti-c-Myc
antibody (data not shown).
As is the case in mammals, ¯ies generate different
ADAR isoforms by alternative splicing (Palladino et al.,
2000b). The inclusion of the alternative exon 3a increases
the spacing between the two dsRDBs in dADAR
(Figure 1A). When the myc-tagged ADAR 3a is replaced
with a myc-tagged ADAR 3/4 protein in the experiment
described above, a heterodimer (Figure 2B) is formed,
indicating that the alternative exon 3a is not important for
dimerization. As a control, the ADAR protein was
incubated with protein G±agarose beads alone and
immunoprecipitated; no cross-reaction was detected. The
formation of a heterodimer was also con®rmed by the
yeast two-hybrid system (data not shown).
Identi®cation of the minimal dimerization domain
To identify and characterize the minimum region required
for dimerization, N- or C-terminal portions of ADAR were
fused to the DNA-binding domain of LexA and tested in
the yeast two-hybrid assay. The deletion endpoints were
chosen so as to generate proteins lacking entire conserved
domains such as the two dsRBDs, the deaminase domain
or the alternatively spliced exon 3a (Figure 3A).
The truncated fusion proteins that retained the
N-terminus of ADAR retained the ability to interact with
full-length ADAR that was fused to the GAL4-AD domain
(Figure 3). The minimum domain that retained the
interaction with full-length ADAR consisted of the
N-terminus and the ®rst dsRBD (1±133) (Figure 3), and
it displayed a positive interaction in a b-galactosidase ®lter
assay after 20 min, which is similar to that obtained with
the full-length proteins. However, the N-terminus alone
(amino acids 1±53) and the ®rst dsRBD (amino acids 53±
133) did not interact with the full-length ADAR when
expressed as independent domains (Figure 3). Neither the
second dsRBD (amino acids 196±273) nor the deaminase
domain (amino acids 270±670) displayed any interaction
when co-expressed with the full-length ADAR (Figure 3).
However, if the b-galactosidase incubation time was
increased from 20 min to >7 h, the two dsRBDs (amino
acids 53±133 and 196±273) displayed a very weak
interaction with full-length ADAR (data not shown).
By deleting the N-terminus (amino acids 1±46), ADAR
lost the ability to dimerize with the full-length protein
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(Figure 3). Therefore, it can be concluded that the minimal
region of ADAR required to form a stable dimer consists
of the N-terminus and the ®rst dsRBD domain (amino
acids 1±133).
RNA binding is required for dimerization
Considering that the ®rst dsRBD is required for dimeriza-
tion, the question of whether RNA was also an essential
component arose. dADAR can bind its own RNA
(L.Keegan, manuscript in preparation). Therefore, in the
yeast two-hybrid assay and in in vitro immunoprecipita-
tion experiments, it can bind to its own transcript. To
discover whether RNA was critical for dimer formation,
mutant proteins were generated in which the dsRNA-
binding activity was disrupted. Advantage was taken of the
homology in dsRBD1 to other proteins that bind dsRNA
such as PKR (Figure 1B), which also forms dimers that are
RNA dependent. PKR is a good model for the dsRBDs of
ADAR, as Samuel and colleagues substituted the ®rst two
dsRBDs of human ADAR1 with those from PKR and
retained partial hADAR1 activity (Liu et al., 2000).
Therefore, with the mutational analysis of PKR as a guide,
a series of point mutations were carried out in dsRBD1 to
eliminate the dsRNA-binding activity of ADAR.
The alanine residues A106 and A110, within the second
a helix of the ®rst dsRBD of ADAR, were independently
mutated to glutamate (A106E and A110E). To con®rm
that A106E and A110E are defective in RNA binding, both
wild-type and mutant proteins were expressed in Pichia
pastoris and puri®ed by Ni2+-NTA af®nity chromato-
graphy. Protein concentrations were normalized, and
®lter-binding assays were performed with increasing
concentrations of protein and a constant amount of
32P-labelled dsRNA. The A106E and A110E mutants are
unable to bind to dsRNA (Figure 4B), and no editing was
detected in vitro (Figure 4A). As in the case of PKR, the
®rst dsRBD of ADAR is essential for binding to dsRNA
regardless of the presence of the intact second dsRBD
(Zhang et al., 2001). Neither mutant was able to interact
with ADAR in a two-hybrid assay (Figure 4C), demon-
strating that the ability to bind dsRNA is required for the
formation of dimers in vivo.
Fig. 1. Structure of Drosophila ADARs. (A) Schematic representation of the two dADAR isoforms, 3a and 3/4. The enzymes contain two dsRBDs and
a deaminase domain (DM). The alternatively spliced exon 3a (111 nucleotides) lies between the two dsRBDs. Amino acid numbers are indicated
below the domains. (B) Amino acid sequence comparison between dADAR and hPKR within the ®rst dsRDB. The amino acids that are identical be-
tween the two proteins are in grey. A schematic representation of the predicted secondary structure of the dsRBD is shown above. The residues con-
served >50% among all dsRBD sequences are shown beneath. (C) Homology within the minimum dimerization domain of the dADAR (AAF63703)
to human ADARs (hADAR1-P55265, hADAR2-P78563, hADAR3-Q9NS39). This alignment was compiled with the web site http://ebiac.uk/clustalw.
The alignment asterisks below represent identical amino acids and the double dots indicate similar amino acids.
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It is possible that the residue changes in the ®rst dsRBD
of ADAR could have affected monomer±monomer inter-
action as well as interfering with RNA contacts. Therefore,
to verify by an independent method that ADAR did not
form a dimer in the absence of dsRNA, we determined the
sedimentation coef®cient of ADAR by centrifugation
through glycerol gradients containing 0.1 M KCl in the
presence or absence of a speci®c RNA substrate
(Figure 4D). In the absence of RNA, ADAR sediments
in the fraction after the BSA standard, as would be
expected from its molecular weight; whereas, in the
presence of RNA, ADAR sediments in all fractions after
aldolase that has a molecular weight of 158 kDa.
Therefore, in the absence of RNA, ADAR behaves as a
monomer; only in the presence of RNA do we see a shift to
a higher molecular weight species.
The sedimentation pro®les depicted in Figure 4D were
determined using an inactive 3/4 isoform. This was
generated by introducing a point mutation in the
deaminase domain whereby the glutamate (E330) that
has been proposed to be involved in proton shuttling was
replaced by alanine (ADAR-E/A) (Lai et al., 1995).
Identical sedimentation pro®les were obtained with both
the inactive and active isoforms (data not shown). This
suggests that an active deaminase domain is not required
for the formation of a protein±RNA complex.
Fig. 2. Dimerization of ADAR protein. (A) Yeast (L40) was cotrans-
formed with plasmids encoding the full-length Adar fused to the LexA
binding domain in the yeast expression vector pBTMK or fused to the
DNA activation domain of GAL4 in the pACT2 vector. Positive
protein±protein interactions were detected as blue colonies after a
b-galactosidase assay. Full-length ADAR forms homodimers, and no
interaction was detected with just the deaminase domain (DM) or with
the controls. The positive control (C+) is the interaction between
PAB1-2 and Paip 1, and the negative control (C-) is the absence of
interaction between PAB1-2 and IRP (Gray et al., 2000). (B) The
ADAR 3a isoform with epitope tags (c-Myc or HA) was transcribed
and translated in vitro. The 3/4 isoform was generated with the anti-
c-Myc epitope tag. The proteins were mixed and then co-immunopreci-
pitated with Myc monoclonal antibody. The immunoprecipitated
proteins were electrophoresed on 8% SDS±polyacrylamide gel and
revealed with an anti-HA polyclonal antibody. Recombinant ADAR 3a
is able to form both homodimers and heterodimers.
Fig. 3. Minimum dimerization domain in ADAR protein. (A) Schematic
representation of Adar deletions expressed in yeast as LexA fusion
proteins. Terminal amino acid residue numbers are indicated. All the
truncated proteins that retained the N-terminus expressed as LexA
fused proteins interacted with full-length ADAR expressed as an AD
fusion protein. A weak interaction was detected when the two dsRBDs
were expressed as independent domains; blue colour appeared after 7±
8 h incubation and is indicated as (±/+), strong interaction with blue
colour after 20 min incubation is indicated as (++), and no interaction
at any time incubation is indicated as (±). (B) Positive protein±protein
interactions between ADAR and truncated ADAR proteins were de-
tected as blue b-galactosidase activity by ®lter lift assay after 20 min.
The amino acid residues encoding the truncated ADAR proteins are
indicated. The black frame highlights the DN-ADAR mutant.
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Dimerization is essential for editing activity
To address the question of whether dimerization is
essential for ADAR activity, a deletion mutant lacking
the N-terminus (amino acids 1±46) was generated,
DN-ADAR (amino acids 46±670). This mutant did not
interact with full-length ADAR in the two-hybrid assay
(Figure 3). Recombinant DN-ADAR containing a His6 tag
at the C-terminus was overexpressed in P.pastoris, puri-
®ed and assayed by western blot analysis and by ®lter-
binding assays with dsRNA. Deletion of the N-terminus
did not disrupt RNA-binding activity (Figure 5B), dem-
onstrating that the mutant protein was folded correctly.
However, DN-ADAR failed to edit dsRNA in vitro
(Figure 5A). Even with higher concentrations of protein,
no editing activity was ever observed (data not shown),
suggesting that, even though the protein can bind RNA,
this is not suf®cient and the active form of ADAR is a
dimer.
The formation of heterodimers can in¯uence
editing activity
The different ADAR isoforms 3a and 3/4 (Figure 1A) in
Drosophila have different binding as well as editing
activities on dsRNA (Figure 6A and B), with ADAR 3/4
being the more active isoform. The isoforms can form
heterodimers, as the domain involved in the dimerization
(NH2±RBD1) is present in both (Figure 2B). To show that
heterodimer formation can affect editing activity, inactive
ADAR 3/4-E/A was overexpressed in P.pastoris, puri®ed
and mixed with ADAR 3a in dsRNA-editing assays. The
puri®ed ADAR 3/4-E/A protein has no editing activity but
binds dsRNA (data not shown).
For protein competition experiments, a concentration
of ADAR 3a (7 ng) was chosen so as to give ~40%
conversion of adenosine to inosine in dsRNA (Figure 6C).
Increasing concentrations of inactive ADAR 3/4-E/A were
added to ADAR 3a. As controls, increasing concentrations
of either ADAR 3/4 (positive control) or the ADAR
A106E mutant that cannot bind dsRNA or form dimers
were also incubated with ADAR 3a. When the 3a and 3/4
isoforms were mixed, an increase in editing activity was
observed (Figure 6C, squares), corresponding to the
increase in active protein present in the reaction. The
editing activity of ADAR 3a was not affected by ADAR
A106E (Figure 6C, triangles), showing that there is no
interaction between ADARs, even at higher concentra-
tions, without RNA binding.
Fig. 4. dsRNA is required for ADAR dimerization. Single point muta-
tions in dsRBD1 were generated so that amino acids A106 and A110
were changed to glutamate. (A) An in vitro editing assay was per-
formed with recombinant proteins and chromatographed on a TLC
plate. The positions of the origin (Org), adenosine (AMP) and
inosine (IMP) are indicated. Increasing amounts of puri®ed proteins
were assayed [ADAR 3a (lanes 2±5), the mutant A106E (lanes 6±9)
and the mutant A110E (lanes 10±13)], and the protein amounts were
10, 23, 70 and 140 ng, respectively. dsRNA without protein is in lane 1.
(B) Filter binding was performed with the same mutant proteins A106E
and A110E as well as with ADAR 3a; the protein amounts are indi-
cated on the x-axis in nanograms. (C) Two-hybrid interactions between
ADAR-LexA and ADAR-AD (positive control) and the two point mu-
tants expressed as LexA fusion proteins and ADAR-AD were detected
as blue b-galactosidase activity by ®lter lift assay. (D) Sedimentation
coef®cient of Drosophila ADAR 3/4-E/A in the presence or absence of
RNA. Protein standards were applied to parallel gradients, and dADAR
was detected by western blot analysis. The position of each protein is
expressed as a percentage of the total number of fractions recovered
from the gradient. The position of dADAR with and without RNA is
indicated by arrows.
Dimerization of dADAR is essential for RNA editing
3425
When the inactive ADAR 3/4-E/A was mixed with 3a,
a decrease in editing activity to 50% was observed
(Figure 6C, diamonds). Interestingly, we never observed
a decrease in editing activity >50% even when inactive 3/4
was added at a 6-fold higher concentration. However,
when DN-ADAR that binds with high af®nity to dsRNA
(Figure 5B) was added, a continuing decrease in editing
activity was observed with increasing concentrations
(Figure 6C, circles). One explanation for this result is
that DN-ADAR binds dsRNA as a monomer and seques-
ters the dsRNA.
Decrease in editing of transcripts in transgenic
Drosophila that contain both an active and an
inactive ADAR isoform
To determine whether the formation of a heterodimer could
in¯uence editing in vivo, transgenic Drosophila were
generated that contained both the wild-type protein and
the inactive isoform ADAR 3/4-E/A. RT±PCR analysis was
performed on edited transcripts to measure editing levels.
Three sites were analysed in two transcripts: one in the cac
transcript; and two in the GluCla transcript. The editing site
chosen in cac was S/G (exon 15) and it is edited to 86% in
adult ¯ies (Figure 7). The K/R site in the GluCla transcript
is also highly edited (55%), and we also examined the N/S
site that is edited to a lower level of 29%. For both the cac
S/G site and the GluCla K/R site, a decrease in editing of
25±30% was observed in RNA from the transgenic ¯ies that
contained the inactive ADAR 3/4 isoform. A slight
decrease of ~4% was observed at the GluCla N/S site.
This result is very surprising, as in the same transcript two
sites are affected differently in the transgenic ¯ies.
Discussion
In this report, we establish that dADAR forms a dimer and,
most interestingly, that this dimerization is essential for
editing activity. The minimum dimerization domain is the
N-terminus and dsRBD1 (Figure 3). Single point muta-
tions within dsRBD1 that destroy RNA-binding activity
Fig. 5. ADAR is active as a dimer. (A) The in vitro editing assay was
performed with either ADAR or DN-ADAR. Increasing amounts
(7, 14, 30 and 50 ng) of both proteins were assayed. The products of
the assay were chromatographed on a TLC plate and the origin (Org),
adenosine (AMP) and inosine (IMP) are indicated. Lane 1 contains
32P-labelled dsRNA incubated without protein. Lanes 2±5 have increas-
ing amounts of ADAR. Lanes 6±9 have increasing amounts of
DN-ADAR. (B) Filter binding was performed with 32P-labelled dsRNA
and increasing amounts of ADAR and DN-ADAR. The protein amounts
are indicated on the x-axis in nanograms. This ®gure represents the
average of two independent experiments.
Fig. 6. Inactive ADAR that retains the minimum dimerization domain
downregulates ADAR activity in vitro. (A) A graph representing the
editing activity of puri®ed ADAR 3a and 3/4 on 32P-labelled dsRNA.
The 3/4 isoform was more active than the 3a isoform. The protein
amounts used are indicated. (B) A graph representing the binding of
puri®ed 3a and 3/4 proteins to 32P-labelled dsRNA. The 3/4 binding
saturated at 250 ng, whereas the 3a isoform bound less dsRNA under
the same experimental conditions. (C) In vitro editing assay was per-
formed with a constant amount of ADAR 3a (7 ng). Increasing amounts
of inactive 3/4-E/A (diamonds), or 3/4 wild-type (squares) or A106E
(triangles) or DN-ADAR (circles) were added to this mixture; the
protein amount that was added is indicated. A106E is a negative control




also affect dimer formation, indicating that binding to
dsRNA is required for dimerization (Figure 4). However,
dimerization can be separated from binding to dsRNA, as a
deletion of the N-terminus (amino acids 1±46) yields an
ADAR monomer that retains the ability to bind dsRNA but
can not dimerize or edit dsRNA (Figure 5). Different
isoforms of ADAR can form heterodimers, and this can
have a signi®cant effect on editing activity both in vitro
(Figure 6C) and in vivo (Figure 7). MacMillan and
colleagues reported that human ADAR2 forms a ternary
complex only in the presence of RNA; they came to this
conclusion after kinetic analysis of the editing of the
GluR-B R/G site (Jaikaran et al., 2002). The in vitro
experiments in the present study were carried out mainly
using dsRNA as a non-speci®c editing substrate, but the
correlation with the results of MacMillan and colleagues
convinces us that speci®c editing sites in ion channel
transcripts behave similarly.
Sequence comparison of >100 dsRBDs has identi®ed
clusters of highly conserved amino acids, and NMR and
X-ray crystallography studies have revealed that the
domain has an a1±b1±b2±b3±a2 secondary structure
(Figure 1B) (Bycroft et al., 1995; Kharrat et al., 1995;
Ryter and Schultz, 1998). The most conserved region of
the dsRBD is the second a helix (Figure 1B) that makes
contacts with the major groove of the dsRNA, and
mutations within this helix can completely destroy RNA
binding (McMillan et al., 1995; Zhang et al., 2001). In the
present study, the amino acids A106 and A110 of ADAR
were independently mutated to glutamate in the a2 helix
in dsRBD1 (Figure 1B). These ADAR mutants are unable
to bind dsRNA as assayed by ®lter binding (Figure 4B), do
not form dimers with full-length ADAR in a yeast two-
hybrid assay (Figure 4C) and do not inhibit RNA editing in
mixing experiments with active ADAR isoforms
(Figure 6C). These experiments suggest that dsRNA is
important for dimer formation and that dsRBD1 from two
different monomers must bind dsRNA. However, the
N-terminus (amino acids 1±53) or dsRBD1 (amino acids
55±133) were unable to interact with the full-length
ADAR when expressed as independent domains (Figure 3),
indicating that dsRNA and a single dsRBD1 are not
suf®cient to form a stable ADAR dimer.
The N-terminus of ADAR is also important for
dimerization, as a truncated ADAR lacking the ®rst 46
amino acids failed to interact with the full-length ADAR
in vivo despite the presence of an intact dsRBD1 (Figure 3).
However, this mutant retained the ability to bind dsRNA
better than wild-type ADAR (Figure 5B). More import-
antly, this mutant was inactive in an in vitro editing assay,
demonstrating that ADAR is only active as a dimer
(Figure 5A). Apparently, dimerization does not increase
the af®nity of ADAR for RNA, since the DN-ADAR not
only binds as well as wild-type protein but even competes
ef®ciently with wild-type ADAR in RNA-editing assays
(Figure 6C). This mutant also demonstrates that, in
contrast to what occurs in ADATs, dimerization and
binding to dsRNA can be separated. Our results do not rule
out the possibility that there are also contacts between
deaminase domains in ADAR dimers.
The ®nding that dimerization of ADAR is mediated by
an N-terminal region and the ®rst dsRBD is reminiscent of
what occurs with other members of the dsRBP gene
family, in particular with RNase III and PKR (Wu and
Kaufman, 1997; Lamontagne et al., 2000). It has been
observed that PKR activity is inhibited by a high
concentration of dsRNA, as the binding of each monomer
to separate RNA molecules precludes the formation of an
active dimer (Chu et al., 1998). ADAR monomers
probably behave in a similar manner, as it has been
shown that both Xenopus ADAR and hADAR2 are
inhibited by excess substrate (Hough and Bass, 1994;
Jaikaran et al., 2002). The concentration of both dsRNA
and ADAR isoforms are probably critical for the equilib-
rium between the inactive monomer and the active dimer
and this could be a way to regulate RNA-editing activity
in vivo. The presence of a high concentration of PKR
pushes the equilibrium from a monomer to a dimer in the
absence of RNA (Nanduri et al., 1998). However, gel
®ltration analysis of partially puri®ed mammalian ADAR1
and ADAR2 shows that the proteins elute as monomers
(O'Connell and Keller, 1994; Maas et al., 1996), and the
sedimentation coef®cient of dADAR in the absence of
RNA suggests it is a monomer (Figure 4D).
To analyse whether the formation of a heterodimer can
affect the ef®ciency of editing, we mixed ADAR 3a (2 nM
dimers) with inactive isoforms in the presence of a 600 base
pair dsRNA. If every editable adenosine in this substrate is
a separate editing site, the concentration of sites is 8 nM.
Consistent with our idea that a minimal editing site must be
large enough to bind an ADAR dimer, the effective
concentration of editing sites is probably lower than 6 nM.
This is clear because DN-ADAR competes for sites at the
lowest concentration added and competes further at high
concentrations. When increasing amounts of the inactive
ADAR 3/4-E/A isoform were added to the 3a active
protein, a progressive reduction in editing activity to 50%
was observed (Figure 6C), but activity did not decrease
further with additional protein. The inactive isoform that is
capable of forming a heterodimer gave this 50% inhibition.
Our interpretation of the mixing experiment with ADAR
Fig. 7. Formation of a heterodimer in Drosophila in¯uences RNA-
editing activity. Two independent RT±PCR reactions were performed
on RNA isolated from transgenic ¯ies containing both wild-type and
the inactive ADAR 3/4-E/A. RNA editing at three different sites in two
transcripts was analysed by sequencing individual clones. Lanes 1, 3
and 5 are sequences from wild-type Canton S, whereas lanes 2, 4 and 6
were obtained from the transgenic ¯ies. Lanes 1 and 2 represent the
percentage of editing at the S/G site in exon 15 in the cac transcript,
lanes 3 and 4 the editing at the K/R site in the GluCla transcript, and
lanes 5 and 6 the GluCla N/S site. The numbers above the bars in the
graph are the numbers of clones sequenced.
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3/4-E/A is that the ADAR 3a±ADAR 3/4-E/A heterodimer
is only half as active as the ADAR 3a homodimer. This loss
in activity is not compensated by the heterodimer being
twice as abundant as the homodimer, because of the
competition for sites. Because the heterodimer is more
abundant, the decrease of >50% at higher concentrations
that is seen with DN-ADAR may be dif®cult to observe with
ADAR 3/4-E/A, although we do not fully understand why
this further decrease is not seen. Interestingly, a similar
downregulation effect occurs when wild-type and ADAR
3/4-E/A isoforms are co-expressed together in Drosophila.
A greater decrease in activity was observed in vitro than
in vivo. An explanation may be that there is more wild-type
protein than the inactive 3/4-E/A protein present or that
different editing sites may require speci®c homodimers or
heterodimers.
The formation of heterodimers between these isoforms
can have an important impact on RNA editing in
Drosophila, considering that the ratio of ADAR 3/4 to
ADAR 3a isoforms increases during development
(Palladino et al., 2000b). Recently, a study of
Drosophila Adar identi®ed a new isoform, highly
expressed in embryo, that is truncated within the
deaminase domain (Ma et al., 2002). Interestingly, this
inactive isoform is expressed predominantly during early
stages of development, and its abundance correlates with
the low level of editing observed during this developmen-
tal stage (Palladino et al., 2000b; Ma et al., 2002). We
believe that any active ADAR present would be seques-
tered by this truncated protein. High expression of inactive
hADAR2 isoforms with truncated C-termini has been also
observed (Gerber et al., 1997; Lai et al., 1997). It is
possible that inactive ADAR isoforms may be required to
downregulate ADAR activity by forming heterodimers.
A remarkable feature of the dsRBDs is their ability to
mediate both RNA±protein and protein±protein inter-
actions with other members of the dsRBP family (Fierro-
Monti and Mathews, 2000); An example is the formation
of heterodimers between the viral E3L protein and PKR;
this interaction inhibits PKR activity in vivo (Romano
et al., 1998). Interestingly, the N-terminus of the dADAR
can interact with other proteins (A.Gallo, unpublished
results). As yet, it is uncertain whether these proteins can
sequester ADAR from the active dimer and/or form a
larger protein complex that modulates editing activity. In
Drosophila, an intriguing link between editing and an
RNA helicase maleless (mle), another dsRBP, has already
been found (Reenan et al., 2000). This RNA helicase
contains two dsRBDs, and it will be interesting to
determine whether ADAR can interact directly with
MLE and bring it to an editing site where it is required.
How can we interpret the evidence for ADAR
dimerization in relation to what is known about editing
targets? Most ADAR substrates may be edited on only one
side of the putative ADAR dimer, and the complex is
probably pseudo-symmetric, as proposed for substrate
recognition by APOBEC (Navaratnam et al., 1998;
Hersberger et al., 1999). A dimeric model for ADAR
predicts that in some cases symmetrical editing may be
seen if there are target adenosine residues on opposite
strands at a ®xed distance apart. In fact, a possible
symmetric editing event has been reported (Herbert and
Rich, 2001) in which ®ve adenosine residues are edited in
a substrate containing the top strand sequence AA-
(N15)-TTT. We propose that the ADAR dimer has active
sites positioned 16 base pairs apart and that each active site
¯ips out and edits a number of adenosines in succession.
Hybrid proteins made between vertebrate ADAR1 and
ADAR2 show that ADAR deaminase domains contribute
to the different target site speci®cities of those proteins
(Wong et al., 2001). The dimer model predicts that
deaminase domain recognition of RNA sequence or
structure 16 bases away from the edited adenosine may
contribute to specifying the editing site. MacMillan and
colleagues showed that a GluR-B R/G site which has only
14 bases of predicted duplex 3¢ to the edited base is not
edited and forms only a monomeric complex with ADAR
(Jaikaran et al., 2002).
We have shown that the dimerization of ADAR
enzymes is essential for deamination and is a key step in
regulating RNA editing. These ®ndings are important in
understanding the enzymatic reaction of ADARs. The
RNA structures formed at editing sites must now be re-
examined for evidence of symmetry. dADAR is a good
model for mammalian ADARs, as it is very homologous in
domain structure and sequence to hADARs, particularly to
hADAR2 (Palladino et al., 2000b). hADAR2 is able to
rescue locomotion defects in Adar mutant Drosophila
(L.Keegan, unpublished results), indicating that mechan-
isms of site recognition in editing of ion channel
transcripts are conserved.
Materials and methods
Plasmids and yeast strains
The analysis of ADAR interactions in yeast was performed by subcloning
the full-length Adar cDNA and deletions of it in frame with BD-lexA in
the pBTMK vector. The selectable markers on this plasmid are Trp1 for
yeast and KanR for E.coli. The full-length Adar was also subcloned in
frame with AD-Gal4 in the pACT2 vector (Clontech) that contains the
leu2 and AmpR markers. All clones were sequenced to ensure that the
correct fusion protein was generated. The lithium acetate method was
used to cotransform the plasmids in the Saccharomyces cerevisiae strain
L40 [MATa; HIS200; trp1-901; leu2-3,112; ade2; LYS2::(lexAop)4-HIS3;
URA3::(lexAop)8-lacZ; GAL4] (Sambrook et al., 1989; Gietz et al.,
1992). The cells containing both plasmids were selected on SD medium
lacking leucine, tryptophan and histidine in the presence of increasing
concentrations of 3-AT. The activation of the reporter genes (HIS3 and
lacZ) was analysed by growth on selective media and by b-galactosidase
®lter lift assay. To con®rm that the recombinant dADAR proteins were
expressed in yeast, whole cell protein extracts were prepared from yeast
(Printen and Sprague, 1994). Western blot analysis was performed with
anti-LexA monoclonal antibody (Clontech) and anti-Gal4-AD mono-
clonal antibody (Clontech) and visualized with the enhanced chemilu-
minescence (ECL) detection system (Amersham Pharmacia Biotech).
Protein puri®cation
See Supplementary data available at The EMBO Journal Online.
Site-directed mutagenesis
See Supplementary data.
Generation of deletion mutants
Serial deletions from the C- and N-termini of ADAR were carried out to
de®ne the minimum region of the protein capable of forming a dimer
with the full-length protein in yeast. Restriction sites were included in
the oligonucleotides so as to facilitate the subcloning of Adar in frame
with the DNA-binding domain of lexA in the pBTMK vector; EcoRI
restriction sites were introduced for the forward oligonucleotides and
BamHI sites for the reverse oligonucleotides. The number in the name
of the oligonucleotide corresponds to nucleotide position in the














The nucleotide sequence of all constructs was con®rmed by sequence
analysis, and western blot analysis was performed with the anti-lexA
monoclonal antibody to ensure the protein was of the expected size in
yeast.
In vitro transcription and translation
Different Adar fusion constructs with either c-Myc or hemagglutinin
(HA) epitope sequences were transcribed and translated in vitro from PCR
products with a rabbit reticulocyte coupled transcription±translation kit
(Promega). Adar 3a and 3/4 with the c-Myc epitope sequence at the
N-terminus was generated by PCR, and the DNA template was Adar-
c-Myc subcloned in the pGBKT7 two-hybrid vector (Clontech). An
oligonucleotide encoding both the T7 promoter and the c-Myc epitope
was used in combination with the reverse oligonucleotide Rev2010±
1995BamHI (see above). Adar 3a with the HA epitope sequence was
generated by PCR, and the DNA template was Adar subcloned in the
pACT2 vector (Clontech). The forward oligonucleotide encoded both
the T7 promoter and the HA epitope tag 5¢ of the Adar sequence and the
reverse oligonucleotide was AD-Rev primer. The sequences of the
oligonucleotides are: c-Myc-Fw primer, 5¢-AAAATTGTAATAC-
GACTCACTATAGGGCGAGCCGCCACCATGGAGGAGCAGAAG-
CTGATC-3¢; HA-Fw primer, 5¢-AAAATTGTAATACGACTCACTA-
TAGGGCGAGCCGCCACCATGTACCCATACGACGTTCCAGATT-
ACGC-3¢; and AD-Rev primer, 5¢-ACTTGCGGGGTTTTTCAGTA-
TCTACGAT-3¢.
PCR reactions were performed in a thermal cycler with Expand Taq
(Roche) and analysed by electrophoresis on an agarose gel. The crude
PCR products (usually 4 ml) were added to 40 ml of the TNT T7 PCR
Quick Master Mix (Promega) in the presence of 2 ml [35S]methionine
(1000 Ci/mmol at 10 mCi/ml) in a ®nal volume of 50 ml and incubated at
30°C for 90 min. The translated proteins were analysed by 8% SDS±
PAGE and autoradiography on X-ray ®lm. Western blot analysis was also
performed with either anti-HA polyclonal or anti-Myc monoclonal
antibodies and revealed by ECL.
Glycerol gradient sedimentation
See Supplementary data.
In vitro protein±protein interaction assay
Equal amounts of the in vitro-translated proteins (either 3a-myc and
3a-HA or 3/4-myc and 3a-HA) were mixed and incubated for 1 h at 30°C.
Then 30 ml of protein G±agarose beads (Roche), 15 ml of anti-c-Myc
monoclonal antibody (or anti-HA polyclonal antibody) and 470 ml of
immunoprecipation buffer (20 mM Tris±HCl pH 7.5, 100 mM NaCl, 1%
Triton X-100, 20% glycerol, 0.5 mM PMSF, 0.7 mg/ml pepstatin and
0.4 mg/mg leupeptin) were added to the proteins and mixed by rotating at
4°C for 90 min. The beads were pelleted by centrifugation at 14 000
r.p.m. for 2 min in a microcentrifuge at 4°C. The beads were washed three
times by pipetting with 500 ml of immunoprecipitation buffer. The
washed beads were boiled in 15 ml of Laemmli buffer for 2 min, and 7 ml
of this was analysed by western blot with either anti-HA-polyclonal (or
anti-c-Myc monoclonal antibodies; data not shown).





Puri®ed proteins were normalized by Bradford assay and mixed with
dsRNA containing 200 fmol of 32P-labelled adenosine. A constant
amount of ADAR 3a (7 ng) and increasing concentrations of different
isoforms [either inactive ADAR 3/4-E/A, ADAR 3/4 (wild-type), A106E
or DN-ADAR] were mixed on ice, and the editing assay was performed at
37°C for 1 h.
Fly strains and RNA editing in vivo
The inactive ADAR 3/4-E/A has an essential glutamate in the active site
of the deaminase domain changed to alanine. The protein bears a FLAG
tag at the N-terminus and a His6 tag at the C-terminus. The UAS-Adar3/4
EA line was generated by coinjection of a pUAST-Adar3/4 EA construct
and helper plasmid into w1118 eggs followed directly by balancing of
stable transformant lines using standard procedures. To look for a
dominant inhibitory effect of overexpressing ADAR 3/4-E/A in a ¯y
containing normal levels of ADAR protein, male ¯ies of the w; UAS-Adar
3/4 EA 4±1/TM3 Sb line were crossed to females of the genotype y, Adar
1F4, w / w, FM6; (mini w+) actin-5C-Gal4/SM5 Cy. Male progeny from
this cross of the genotype w, FM6; (mini w+) actin-5C-Gal4; (mini
w+)UAS-Adar3/4 EA were selected for RNA extraction to compare RNA-
editing levels with those seen in wild-type Canton-S ¯ies. Individual
clones were sequenced from two independent RT±PCR reactions from
rescue and control ¯ies.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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